New York, November 12th / PRNewswire / -- Pomerantz LLP represents and stands for HCA Healthcare, Inc ("HCA" or "the company") ( NYSE : HCA ). Investors concerned about these claims can contact Danielle Peyton at the email address [ email protected ], telephone 646-581-9980, extension 7980.

This investigation involves whether HCA and some of its senior executives and/or directors are engaged in securities fraud or other illegal business practices.

[Click here to learn about joining the class action.]

On July 14, 2026, HCA issued a press release disclosing its preliminary financial and operational results for the second quarter of 2026. Among other things, HCA significantly lowered its annual profit forecast for 2026, stating that an unfavorable change in the company's payer structure affected revenue by approximately $400 million for that quarter.

Affected by this news, the stock price of HCA fell by $27.14 on July 14, 2026, a decrease of 6.95%, closing at $363.60 per share.

Pomerantz LLP has offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, and is recognized as one of the leading law firms in the fields of corporate law, securities law, and class action litigation. The firm was founded by the late Abraham L Pomerantz, who was known as the "dean" of the class action litigation field and pioneered this area of practice. More than 85 years later, Pomerantz continues this tradition, fighting for the rights of victims of securities fraud, breach of fiduciary duty, and corporate misconduct. The firm has secured millions of dollars in compensation on behalf of its class members. For more information, please refer to www.pomlaw.com.

Lawyer advertisement. Past results do not guarantee similar outcomes in the future.

Contact Information: